Artificial Intelligence In Medicine Market Report 2026

Artificial Intelligence In Medicine Market Overview

• Artificial Intelligence In Medicine market size has reached to $15.6 billion in 2025 • Expected to grow to $80.59 billion in 2030 at a compound annual growth rate (CAGR) of 38.8% • Growth Driver: Surge In Remote Patient Monitoring Boosts AI Adoption In Healthcare • Market Trend: Advanced Robotic Tools By Smith & Nephew Transforming Orthopedic Practices • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Artificial Intelligence In Medicine Market?

Artificial intelligence in medicine refers to the application of artificial intelligence technologies, such as machine learning and data analysis, to enhance diagnosis, treatment, and healthcare management. It aids in faster and more accurate disease detection, personalized treatment plans, and improved overall efficiency in medical processes. The main types of artificial intelligence in medicine are hardware, software, and services. The capabilities of hardware such as multi-purpose computers, embedded motherboards, and fanless embedded systems are key building blocks for medical devices that rely on AI. The various technologies include machine learning, natural language processing, context-aware processing, and computer vision. These are used in various applications such as medical administration and support, patient management, research and development, others, and also by various end users such as hospitals, clinics, and research institutions.

What Is The Artificial Intelligence In Medicine Market Growth Forecast?

The artificial intelligence in medicine market size is expected to see exponential growth in the next few years. It will grow to $80.59 billion in 2030 at a compound annual growth rate (CAGR) of 38.8%. The growth in the forecast period can be attributed to increasing adoption of ai-enabled personalized medicine, rising investments in healthcare ai platforms, expansion of remote and digital care models, growing use of predictive analytics in population health, increasing integration of ai across clinical workflows. Major trends in the forecast period include increasing deployment of AI-based clinical decision support systems, rising adoption of personalized treatment algorithms, growing use of ai for disease risk prediction, expansion of ai applications in hospital operations, enhanced focus on data-driven patient management.

What Is The Driver Of The Artificial Intelligence In Medicine Market?

The increasing interest in real-time remote patient monitoring (RPM) systems is expected to propel the growth of artificial intelligence in the medicine market going forward. A remote patient monitoring system is a technology-driven healthcare solution designed to monitor patients' health outside of traditional healthcare settings. Artificial intelligence (AI) in medicine has significantly transformed remote patient monitoring by leveraging advanced algorithms to analyze extensive patient data, offering predictive insights and enabling personalized care. For instance, in November 2025, according to Statistics Canada, a Canada-based government agency, Canadians residing with the highest proportions of individuals who had virtual appointments only were Newfoundland and Labrador (13.2%), British Columbia (10.6%), and Nova Scotia (10.4%). Saskatchewan (2.1%), Alberta (2.4%), and Manitoba (3.3%) had the smallest proportions of those who had virtual appointments only. Therefore, the increasing interest in real-time remote patient monitoring (RPM) systems is driving the growth of artificial intelligence in the medicine market.

Key Players In The Global Artificial Intelligence In Medicine Market

Major companies operating in the artificial intelligence in medicine market are Google LLC, Microsoft Corporation, Intel Corporation, IBM Corporation, Medtronic PLC, Nvidia Corporation, Siemens Healthineers AG, Philips Healthcare, Babylon Healthcare Services Ltd., Komodo Health Inc., Modernizing Medicine Inc., Viz.ai Inc., Butterfly Network Inc., Augmedix, AiCure LLC, HealthTap Inc., Welltok Inc., Enlitic Inc., PathAI Inc., Nano-X Imaging Ltd., Berg LLC, Insitro, Sense.ly Inc., Subtle Medical Inc., Medasense Biometrics Limited, Immunai, Atomwise Inc., Freenome Holdings Inc., CloudMedX Inc.

Global Artificial Intelligence In Medicine Market Trends and Insights

Major companies operating in the artificial intelligence in the medicine market are focused on developing innovative solutions, such as AI-powered platforms, to provide reliable services to customers. An AI-powered platform is a software solution incorporating artificial intelligence (AI) technologies to automate tasks, analyze data, and make predictions. For instance, in April 2023, OM1 Inc., a US-based digital health company, launched PhenOM. It uses real-world data and advanced analytics to identify unique digital phenotypes associated with conditions and outcomes, creating fingerprints for different patient groups. PhenOM can analyze individual patient data to predict risks, highlight opportunities for intervention, and inform treatment decisions.

What Are Latest Mergers And Acquisitions In The Artificial Intelligence In Medicine Market?

In July 2024, GE HealthCare, a US-based medical technology company, acquired Intelligent Ultrasound Group PLC's clinical artificial intelligence (AI) software business for approximately $51 million. This acquisition enhances GE HealthCare's commitment to enhancing its ultrasound portfolio with innovative AI-driven image recognition technology, aimed at improving exam accuracy and efficiency in patient care. Intelligent Ultrasound Group PLC is a UK-based company that specializes in AI-based clinical image analysis tools for diagnostic medical ultrasound.

What Defines the Artificial Intelligence In Medicine Market?

The artificial intelligence (AI) in the medicine market consists of revenues earned by entities by providing services such as diagnostic assistance, drug discovery and development, patient management, and monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence (AI) in the medicine market also includes sales of diagnostic imaging devices, smart medical devices, and genomic sequencing equipment. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Artificial Intelligence In Medicine Market Report 2026?

The artificial intelligence in medicine market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence in medicine industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.